ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0340

Associations with fragility fractures in a population with inflammatory bowel disease (IBD): An observational study.

Chern Lee Choy1, Hamzah Amin2 and marwan Bukhari3, 1University Hospitals of Morecambe Bay NHS Foundation Trust, Barrow-In-Furness, United Kingdom, 2Lancaster University, Lancaster, United Kingdom, 3University Hospitals of Morecambe bay NHS foundation trust, Lancaster, United Kingdom

Meeting: ACR Convergence 2025

Keywords: Bone density, Dual energy x-ray absorptiometry (DEXA), Fracture, glucocorticoids, osteoporosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0337–0356) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: It is well recognized that inflammatory bowel disease (IBD) is associated with osteoporosis and fragility fractures, likely due to multiple factors, including systemic inflammation, corticosteroid use, malabsorption etc. Nonetheless, the exact mechanism for fractures in IBD patients is still unclear. There are multiple studies working with small cohorts, supporting different predictors for fracture risk, yet it remains to be elucidated. This study aims to evaluate the association of demographic and various predictors with fracture risk in IBD patients on and off steroids.

Methods: A retrospective observational study was conducted in IBD patients who had a dual-energy X-ray absorptiometry (DEXA) scan done in the North West of England between 2004 and 2019. Data analysed included demographics, family history of fractures, FRAX™ risk factors, total femur BMD, L1-L4 BMD, fat percentages at different sites including total body, abdomen and both femurs. Chi-square tests were used to assess statistically significant associations between categorical variables, while Student’s t-tests were used for continuous variables. Univariate and multivariate logistic regression models were then utilised to identify significant predictors associated with the development of fractures. Results are shown in both Table 1 and 2.

Results: A total of 1827 patients with IBD were analysed, in which 1495 (81.8%) were female. The mean age at DEXA scan was 65.2 (SD 13.17) years. Fractures occurred in 674 (36.9%) patients, including 573 (31.4%) females and 101 (5.5%) males. Patient with fractures had a higher fat percentage in total, abdominal and femoral regions. Fractures were also associated with lower BMD at all measured sites including L1-L4, femoral necks and total femur.Of the 1252 (68.5%) patients not using steroids, 501 (40.0%) reported fractures, while 88 (24.1%) of the 361 current steroid users had fractures. 65 (44.5%) of the 146 (8.0%) patients with rheumatoid arthritis also reported fractures. 64 out of the 647 patients with fractures reported previous fractures.The multivariate model identified abdominal fat percentage, both right and left femur fat percentages, dual femur fat percentages, both right and left total femur BMD, to be significant predictors of fractures in IBD patients. The right femur fat percentage showed a wide confidence interval (OR 36.40, 95% CI: 1.13–1170.67, p = 0.042), possibly due to sample variability or multicollinearity, though the association remains statistically significant and may be clinically relevant.

Conclusion: Our study showed that lower total femoral BMD is associated with an increased fracture risk in patients with IBD, reinforcing the association between reduced BMD and higher fracture likelihood. Moreover, higher fat percentages in both femoral regions elevate fracture risk, suggesting that body fat composition at different sites may play a role in the development of fragility fractures. It is notable that fractures occurred in a significant proportion of steroid-naive patients with IBD, suggesting that IBD itself contributes to the development of fragility fractures.

Supporting image 1Table 1. Baseline Characteristics of IBD patients

Supporting image 2Table 2. Univariate and Multivariate model analysis for predictors of fracture in IBD patients


Disclosures: C. Choy: None; H. Amin: None; m. Bukhari: None.

To cite this abstract in AMA style:

Choy C, Amin H, Bukhari m. Associations with fragility fractures in a population with inflammatory bowel disease (IBD): An observational study. [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/associations-with-fragility-fractures-in-a-population-with-inflammatory-bowel-disease-ibd-an-observational-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-with-fragility-fractures-in-a-population-with-inflammatory-bowel-disease-ibd-an-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology